⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Oral Contraceptives and Female Hormone Health
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-13 — Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried: Huberman Lab Essentials with Dr. Sara Gottfried (podcast, no new data): weighs OC benefits (ovarian-cancer risk reduction) against progestin-related inflammation, elevated SHBG, lowered free testosterone, and possible clitoral atrophy, and notes non-OC options for dysmenorrhea. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried
13-aug-2026
novelty 3
per-area 3
strengthens